Ambu A/S (OTCMKTS:AMBBY) Issues Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) posted its quarterly earnings data on Thursday. The company reported $0.14 EPS for the quarter, Zacks reports. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Stock Performance

OTCMKTS:AMBBY traded up $1.50 during midday trading on Thursday, reaching $13.60. The stock had a trading volume of 1,000 shares, compared to its average volume of 45. The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08. The stock has a market cap of $3.20 billion, a P/E ratio of 44.00 and a beta of 0.86. The firm has a fifty day simple moving average of $11.10 and a two-hundred day simple moving average of $10.99. Ambu A/S has a 12-month low of $8.54 and a 12-month high of $14.18.

Analyst Ratings Changes

Separately, UBS Group cut Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Ambu A/S currently has a consensus rating of “Hold”.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.